Dr. Clark is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
55 Fruit St
Hematology Oncology Yaw 7
Boston, MA 02114Phone+1 617-724-4000Fax+1 617-726-0452- Is this information wrong?
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1981 - 1985
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1978 - 1981
Tufts University School of MedicineClass of 1978
Certifications & Licensure
MA State Medical License 1994 - 2025
ME State Medical License 2020 - 2021
RI State Medical License 1988 - 1996
MD State Medical License 1984 - 1988- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Combination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced, Recurrent, or Metastatic Colorectal Cancer Start of enrollment: 2000 May 01
- Bevacizumab, Fluorouracil, and External-Beam Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer Start of enrollment: 2002 Aug 01
- A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer Start of enrollment: 2006 Apr 19
Publications & Presentations
PubMed
- A multicenter phase Ia study of AbGn-107, a novel antibody-drug conjugate, in patients with advanced gastrointestinal cancer.Andrew H Ko, Andrew L Coveler, Benjamin L Schlechter, Tanios Bekaii-Saab, Brian M Wolpin, Jeffrey W Clark, Bruno Bockorny, Li-Yuan Bai, Yu-Chin Lin, Evelyn Chiang, Pet...> ;Investigational New Drugs. 2024 Apr 1
- Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders.Huffman, B., Singh, H., Ali, L., Horick, N., Wang, S., Hoffman, M., Metayer, K., Murray, S., Bird, A., Abrams, T., Biller, L., Chan, J., Meyerhardt, J., McCleary, N., ...> ;Journal for Immunotherapy of Cancer. 2024 Jan 25
- Patient-Reported Outcomes, Tumor Markers, and Survival Outcomes in Advanced GI Cancer.Joy X Jarnagin, Anurag Saraf, Islam Baiev, Gary Chi, Emily E van Seventer, Amirkasra Mojtahed, Jill N Allen, Jeffrey W Clark, Lawrence Blaszkowsky, Bruce J Giantonio, ...> ;JAMA Network Open. 2023 Nov 1
- Join now to see all
Other
- Adjuvant therapy for resected stage III (node-positive) colon cancerClark JW, Sanoff HK
http://www.uptodate.com/contents/adjuvant-therapy-for-resected-stage-iii-node-positive-colon-cancer
UpToDate, Wolters Kluwer Health - 2013-04-09 - Systemic chemotherapy for metastatic colorectal cancer: Completed clinical trialsClark JW, Grothey A
http://www.uptodate.com/contents/systemic-chemotherapy-for-metastatic-colorectal-cancer-completed-cl
UpToDate, Wolters Kluwer Health - 2013-02-25 - Systemic chemotherapy for metastatic colorectal cancer: General principlesClark JW, Grothey A
http://www.uptodate.com/contents/systemic-chemotherapy-for-metastatic-colorectal-cancer-general-prin
UpToDate, Wolters Kluwer Health - 2013-03-18 - Join now to see all
Press Mentions
5 Colon Cancer Symptoms You Should Know—Even if You’re YoungApril 20th, 2018
Colon Cancer Patient Story: Rick & Sally MastalerzJune 29th, 2023
Professional Memberships
- Member
- Member
- Member
Hospital Affiliations
Massachusetts General HospitalBoston, Massachusetts
Dana-Farber Cancer InstituteBoston, Massachusetts
Newton-Wellesley HospitalNewton Lower Falls, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
